Cue Biopharma (CUE) Insider Trading
- $5,069,514.01
- $2,008,373.07
- Dec. 16, 2024
- Daniel R Passeri
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 16, 2024 | CEO | 30,000 | $1.03 | Buy | $30,900.00 | |
| Aug. 25, 2023 | Insider | 4,000 | $2.76 | Buy | $11,040.00 | |
| Aug. 14, 2023 | CEO | 3,000 | $2.86 | Buy | $8,580.00 | |
| March 23, 2023 | Director | 9,325 | $3.28 | Sell | $30,586.00 | |
| May 23, 2022 | Director | 150,000 | $3.52 | Buy | $528,000.00 | |
| March 31, 2022 | Director | 735,000 | $4.76 | Buy | $3,498,600.00 | |
| Oct. 1, 2021 | CFO | 1,251 | $14.21 | Sell | $17,776.71 | |
| Sept. 24, 2021 | CEO | 3,400 | $14.72 | Buy | $50,048.00 | |
| Sept. 23, 2021 | Insider | 20,000 | $15.23 | Sell | $304,600.00 | |
| March 15, 2021 | Insider | 13,000 | $15.10 | Sell | $196,300.00 | |
| Feb. 16, 2021 | Insider | 16,000 | $15.15 | Sell | $242,400.00 | |
| Jan. 20, 2021 | Insider | 2,720 | $15.07 | Buy | $40,990.40 | |
| Sept. 29, 2020 | Director | 5,000 | $15.00 | Buy | $75,000.00 | |
| Aug. 5, 2020 | SVP | 13,274 | $20.00 | Sell | $265,480.00 | |
| Aug. 5, 2020 | Insider | 800 | $20.01 | Sell | $16,008.00 | |
| Aug. 3, 2020 | Insider | 5,800 | $20.01 | Sell | $116,058.00 | |
| Aug. 3, 2020 | SVP | 6,425 | $20.00 | Sell | $128,500.00 | |
| June 24, 2020 | Director | 7,500 | $24.88 | Buy | $186,600.00 | |
| Dec. 31, 2019 | Director | 9,000 | $15.71 | Sell | $141,390.00 | |
| Dec. 27, 2019 | Director | 9,000 | $17.24 | Sell | $155,160.00 | |
| Dec. 19, 2019 | Director | 4,000 | $17.00 | Sell | $68,000.00 | |
| Dec. 17, 2019 | Director | 20,732 | $15.73 | Sell | $326,114.36 | |
| June 21, 2019 | CEO | 1,377 | $7.26 | Buy | $9,997.02 | |
| June 10, 2019 | SVP | 16,938 | $7.83 | Buy | $132,624.54 | |
| June 6, 2019 | CEO | 3,000 | $6.90 | Buy | $20,700.00 | |
| Dec. 31, 2018 | Director | 18,521 | $4.64 | Buy | $85,937.44 | |
| Dec. 28, 2018 | Director | 7,000 | $4.62 | Buy | $32,340.00 | |
| Dec. 26, 2018 | Director | 19,647 | $4.29 | Buy | $84,285.63 | |
| Dec. 21, 2018 | Director | 10,000 | $4.49 | Buy | $44,900.00 | |
| Dec. 21, 2018 | Insider | 2,000 | $4.37 | Buy | $8,740.00 | |
| Dec. 19, 2018 | Director | 400 | $5.00 | Buy | $2,000.00 | |
| Dec. 17, 2018 | Director | 10,000 | $5.48 | Buy | $54,800.00 | |
| Dec. 13, 2018 | Director | 10,000 | $5.06 | Buy | $50,600.00 | |
| Dec. 11, 2018 | Director | 7,543 | $4.86 | Buy | $36,658.98 | |
| Aug. 29, 2018 | VP | 1,000 | $8.48 | Buy | $8,480.00 | |
| Aug. 16, 2018 | CEO | 6,000 | $8.09 | Buy | $48,540.00 | |
| June 29, 2018 | CEO | 1,600 | $11.97 | Buy | $19,152.00 |
Insiders are both buying and selling Cue Biopharma stock.
The insider traders at Cue Biopharma are: Christopher A Marlett, Daniel R Passeri, Anish Suri, Colin Sandercock, Kenneth Pienta, Anthony Digiandomenico, Aaron G.L. Fletcher, Christopher A. Marlett, Kerri-Ann Millar, Peter A Kiener, and Cameron Gray
The most active insider trader at Cue Biopharma is Christopher A Marlett with 7 trades.
Anish Suri has sold the most Cue Biopharma stock with a total value of $741,266.00.
Aaron G.L. Fletcher has bought the most Cue Biopharma stock with a total value of $4,741,200.00.
The most recent insider trade for Cue Biopharma was on Dec. 16, 2024.
The single biggest insider buy for Cue Biopharma was from Aaron G.L. Fletcher with a total value of $3,498,600.00 on March 31, 2022.
The single biggest insider sell for Cue Biopharma was from Christopher A Marlett with a total value of $326,114.36 on Dec. 17, 2019.